Malawi Cancer Outcomes Research Program (M-CORP)
马拉维癌症结果研究计划 (M-CORP)
基本信息
- 批准号:10223673
- 负责人:
- 金额:$ 26.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AIDS Malignancy ConsortiumAIDS related cancerAcquired Immunodeficiency SyndromeAddressAfrica South of the SaharaAfricanCancer BurdenCancer ControlCervical Cancer ScreeningCessation of lifeClinical TrialsCollaborationsCountryDatabasesEducational CurriculumEnsureEnvironmentEpidemiologyFoundationsFundingGenerationsGrantHIV/TBHuman DevelopmentInstitutionInternationalLeadershipLymphomaMalariaMalawiMalignant NeoplasmsMalignant neoplasm of cervix uteriMalignant neoplasm of esophagusMedicineMentorsNational Cancer InstituteNorth CarolinaOutcomeOutcomes ResearchPostdoctoral FellowProgram EvaluationResearchResearch PersonnelResearch PriorityResearch Project GrantsTestingTimeTraining ProgramsTranslational ResearchUSAIDUniversitiesanticancer researchbasecancer clinical trialcareercollegeexperienceindexinginvestigator trainingmalignant breast neoplasmmultidisciplinaryprogramsskillssuccesstraining opportunity
项目摘要
PROJECT SUMMARY
Globally, there are more deaths from cancer than from HIV, tuberculosis, and malaria combined. In 2018, there
were more than 18 million new cancer cases and 9.5 million cancer deaths worldwide, and, by 2030, these
numbers will increase by at least 50%. Countries with low or medium Human Development Index account for
more than 60% of cancer cases and 70% of cancer deaths. Cancer deaths in sub-Saharan Africa occur
disproportionately from cancers that are preventable and/or curable including lymphoma, cervical cancer and
breast cancer. Addressing the substantial burden of cancer requires a new generation of cancer
researchers who can test hypotheses in the African context. The University of North Carolina Project-
Malawi (UNCPM) has a rich cancer research environment that includes participation in the National Cancer
Institute (NCI) U54 consortium for HIV associated malignancies, the AIDS Malignancy Consortium, the
International Epidemiologic Databases to Evaluate AIDS (IeDEA), NCI African Esophageal Cancer
Consortium, and a USAID-funded cervical cancer screening study. To date, UNCPM has had significant
success in cancer clinical trials and translational research projects, and in establishing a handful of early-
career investigators, but momentum is needed to build on this foundation. First, large improvements in cancer
control in Malawi require approaches that extend beyond clinical trials to cancer outcomes research, a broader
approach that requires unique skills. At this time, there are few cancer researchers with both the necessary
cancer research skills and the local experience to develop cancer outcomes solutions adapted to the Malawian
context. Second, there is no defined pipeline for early-career cancer research capacity. Finally, there are few
opportunities for successful Malawian investigators to obtain the additional skills and experience necessary to
be competitive for independent research funding. To address these gaps, we propose to establish the Malawi
Cancer Outcomes Research Program (M-CORP). This application is led by UNC in conjunction with the
University of Malawi College of Medicine (COM) and in collaboration with other national and international
institutions and training programs. M-CORP aims to increase the cadre of trained investigators who can pursue
independent research careers by: 1) establishing a robust curriculum and training opportunities across the
continuum of cancer outcomes research specific to the Malawian environment and research priorities; 2)
supporting advanced degrees; and 3) overcoming obstacles to research independence by providing post-
doctoral opportunities including mentored pilot grants. We will use a multi-PD leadership strategy based at both
UNC and UNCPM that will optimize our strengths across the spectrum of cancer outcomes research. An
exceptional pool of multidisciplinary mentors, a detailed plan for program evaluation, and robust, broad-based
partnerships between UNC and Malawian institutions ensure that M-CORP objectives will be met and will
establish Malawi as an internationally recognized center of excellence for cancer outcomes research.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Lameck Chinula其他文献
Lameck Chinula的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Lameck Chinula', 18)}}的其他基金
Malawi Cancer Outcomes Research Program (M-CORP)
马拉维癌症结果研究计划 (M-CORP)
- 批准号:
10613541 - 财政年份:2021
- 资助金额:
$ 26.9万 - 项目类别:
Malawi Cancer Outcomes Research Program (M-CORP)
马拉维癌症结果研究计划 (M-CORP)
- 批准号:
10402880 - 财政年份:2021
- 资助金额:
$ 26.9万 - 项目类别:
A novel cervical cancer screen-and-treat demonstration project with HPV self-testing and thermocoagulation for HIV-infected women in Malawi
针对马拉维感染艾滋病毒的妇女开展的新型宫颈癌筛查和治疗示范项目,包括 HPV 自检和热凝
- 批准号:
10020969 - 财政年份:2019
- 资助金额:
$ 26.9万 - 项目类别:
相似海外基金
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6566071 - 财政年份:2001
- 资助金额:
$ 26.9万 - 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6423242 - 财政年份:2000
- 资助金额:
$ 26.9万 - 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6504219 - 财政年份:2000
- 资助金额:
$ 26.9万 - 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6303902 - 财政年份:1999
- 资助金额:
$ 26.9万 - 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6297230 - 财政年份:1998
- 资助金额:
$ 26.9万 - 项目类别:
NCI AIDS RELATED CANCER COHORT STUDY (ACCS)
NCI 艾滋病相关癌症队列研究 (ACCS)
- 批准号:
6263862 - 财政年份:1998
- 资助金额:
$ 26.9万 - 项目类别:
Search for specific modulators of the inflammatory resp onse in AIDS related cancer
寻找艾滋病相关癌症中炎症反应的特异性调节剂
- 批准号:
nhmrc : 960853 - 财政年份:1996
- 资助金额:
$ 26.9万 - 项目类别:
CARG - Research